Neurogenic bladder in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine

Citation
K. Satoh et al., Neurogenic bladder in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine, J NEUR SCI, 183(1), 2001, pp. 1-4
Citations number
23
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF THE NEUROLOGICAL SCIENCES
ISSN journal
0022510X → ACNP
Volume
183
Issue
1
Year of publication
2001
Pages
1 - 4
Database
ISI
SICI code
0022-510X(20010115)183:1<1:NBILMS>2.0.ZU;2-X
Abstract
Autonomic dysfunction, as well as neuromuscular involvement, is a common ma nifestation of Lambert-Eaton myasthenic syndrome (LEMS). Dry mouth and impo tence have been described as typical features of autonomic dysfunction, but neurogenic bladder is infrequent or subclinical in LEMS. We report a patie nt with neurogenic bladder secondary to LEMS whose condition responded to 3 ,4-diaminopyridine (3,4-DAP). In this patient's serum, results of repeated measurement with P/Q-type VGCC antibodies proved positive, but not with N-t ype VGCC and synaptotagmin antibodies. A review of the literature turned up a few patients with voiding dysfunction related to LEMS, but no urodynamic studies were done on these patients. Ours is the first case in which 3,3-D AP was efficacious in treating LEMS and neurogenic bladder. Responses of 3, 4-DAP in urodynamic studies suggest that in this: LEMS patient neurogenic b ladder was caused by defective neurotransmission both in the autonomic detr usor and skeletal abdominal muscles. (C) 2001 Published by Elsevier Science B.V.